TRIPS is an online seminar series that hosts speakers discussing science-informed presentations and discussions about psychedelics to educate healthcare professionals. This series was created to guide healthcare providers and students preparing to be professionals towards the most relevant, pragmatic, and essential information about psychedelic-assisted therapy, changing legal statuses, and harm reduction approaches in order to better serve clients and communities.
This seminar series is a fundraiser for our clinical trial of MDMA-assisted psychotherapy for social anxiety disorder that Portland Psychotherapy investigators are preparing for and starting in the Fall of 2021. All proceeds after presenter remuneration will go to fund this clinical trial.
These presentations are hosted through Zoom. Each presentation will be approximately 30 minutes with a 30-minute Q&A discussion afterward. Presentations will be recorded and sent to anyone who registers for the event. The recording will be available for 30 days after it has been sent to registered attendees.
Cancellation Policy: We charge a $10 administration fee for cancellations made by participants more than two weeks before the training event. For cancellations within two weeks of the training event, we will refund 50% of the tuition after subtracting the administration fee. Alternately, participants may elect to apply 100% of their tuition to a future TRIPS training event. No refunds will be given after training events.
Time: Every 2nd Friday of the month from 12:00 PM – 1:00 PM (Pacific Time)
Location: Virtual (through Zoom)
May 14th, 2021 – Research on MDMA and Psychedelic-Assisted Therapy: An Overview of the Evidence for Clinicians with Jason Luoma, Ph.D.
This presentation is for those who want to understand the breadth of the existing research on the effectiveness of psychedelic and MDMA-assisted therapy. We will review all existing placebo-controlled randomized trials, as well as open trials. Much of this presentation is based on a recent meta-analysis that this presenter published. Attendees will walk away with a broad understanding of the strength and breadth of the existing data on psychedelic assisted therapy and how it compares to other treatments.
June 11th, 2021 – Becoming a Psychedelic-Informed Therapist: Toward Developing Your Own Practice with Nathan Gates, M.A.
Psychedelic medicine seems poised at the cusp of a major boom, potentially evoking major changes in the way psychological suffering is treated. Established and developing professionals alike may find themselves wondering how psychedelic-assisted therapy might affect their practice, and how they could get involved. There are a number of ways in which psychedelic-assisted psychotherapy differs significantly from most models of practice that clinicians have been trained in over the last few decades. These differences may force our field to revisit numerous habits and patterns of behavior that have both consciously and unconsciously shaped the current practice of therapy. At the moment, while best practices are still very much in question, there remain far more questions than answers. For those eager to integrate psychedelic medicines into their work, becoming a psychedelic-assisted psychotherapist may still seem more aspirational than realistic. In this seminar, we will discuss some of the ways in which psychedelic-assisted psychotherapy may overlap with skills and stances we already hold. Additionally, psychedelic practice may require us to adjust our skill sets, clarify our ideas about our role in facilitating therapeutic change, and perhaps even adapt our worldview. Allowing psychedelic experiencing to inform our approach as therapists is a reasonable first step towards integrating them into our practices. In this way, becoming a psychedelic-informed therapist may be a crucial first step towards becoming a psychedelic-assisted psychotherapist.
September 10th, 2021 – Cultural Considerations in Outreach to and Assessment of Minoritized/Marginalized Individuals in Psychedelic-Assisted Psychotherapy with Terence Ching, Ph.D.
With the psychedelic renaissance gaining momentum, there is growing consensus that in order to conduct psychedelic-assisted psychotherapy ethically and equitably, there is a need to improve minoritized or marginalized individuals’ access to these therapies. This presentation will first cover some barriers to access among communities traditionally underrepresented in the above-ground of psychedelic-assisted psychotherapy. Next, these barriers to access will be contextualized as extrapharmacological factors (i.e., set and setting) that may influence the process and outcomes of psychedelic-assisted psychotherapy. Lastly, this presentation will discuss how to assess some culturally relevant factors which may be implicated in the presenting complaints of individuals seeking psychedelic-assisted psychotherapy. *Note about content: This presentation stems from the lived experiences and professional training of the presenter, and necessarily covers only a small and nuanced part of the bigger diversity, equity, and inclusion picture in the context of psychedelic-assisted psychotherapy. It is encouraged for attendees to continue practicing cultural humility as they endeavor to decolonize and diversify their own practice of psychedelic-assisted psychotherapy.
More Dates To Be Announced
Please check back in or sign up for our newsletter to check out additional presentations added.
OTHER EVENTS RELATED TO PSYCHEDELICS
May 28th, 2021 – Lunchtime Panel Discussion: Psilocybin Therapy and Mental Health Care in Oregon: What is Happening and Where do We Need to Go from Here?
- December 11th, 2020 – Ethical and Legal Considerations in Providing Psychedelic Integration Therapy with Brian Pilecki, Ph.D. & Jason Luoma, Ph.D.
- January 8th, 2021 – What’s It Like to Trip? The Patient Experience in Psychedelic-Assisted Therapy with Brian Pilecki, Ph.D.
- February 12th, 2021 – Returning From All: Integrating 5-MeO-DMT Experiences in Psychotherapy with Rafael Lancelotta, M.S.
- March 12th, 2021 – What does Psilocybin-Assisted Therapy for Depression Look Like? A Clinical Case Presentation based on a Recent Clinical Trial from Johns Hopkins with Alan K. Davis, Ph.D.
If you would like to stay up to date on information about the TRIPS seminar series, you can join our newsletter by clicking on the button above.
Portland Psychotherapy is also hosting an Ethical and Legal Considerations in Psychedelic Integration Therapy course in May of 2021. Check it out and sign up for it here.